Similar articles

• Dual-specific T cells combine proliferation and antitumor activity.

  Kershaw MH, Westwood JA, Hwu P. Kershaw MH, et al. Nat Biotechnol. 2002 Dec;20(12):1221-7. doi: 10.1038/nbt756. Epub 2002 Nov 4. Nat Biotechnol. 2002. PMID: 12415288
• A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.

  Singh NP, Yolcu ES, Taylor DD, Gercel-Taylor C, Metzinger DS, Dreisbach SK, Shirwan H. Singh NP, et al. Cancer Res. 2003 Jul 15;63(14):4067-73. Cancer Res. 2003. PMID: 12874008
• A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.

  Moeller M, Haynes NM, Trapani JA, Teng MW, Jackson JT, Tanner JE, Cerutti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK. Moeller M, et al. Cancer Gene Ther. 2004 May;11(5):371-9. doi: 10.1038/sj.cgt.7700710. Cancer Gene Ther. 2004. PMID: 15060573
• Antigen choice in adoptive T-cell therapy of cancer.

  Offringa R. Offringa R. Curr Opin Immunol. 2009 Apr;21(2):190-9. doi: 10.1016/j.coi.2009.02.006. Epub 2009 Mar 16. Curr Opin Immunol. 2009. PMID: 19297140 Review.
• Genetic redirection of T cells for cancer therapy.

  Westwood JA, Kershaw MH. Westwood JA, et al. J Leukoc Biol. 2010 May;87(5):791-803. doi: 10.1189/jlb.1209824. Epub 2010 Feb 23. J Leukoc Biol. 2010. PMID: 20179152 Review.